1. 方法論と範囲
1.1. 調査方法
1.2. 調査目的と調査範囲
2. 定義と概要
3. エグゼクティブ・サマリー
3.1. 製品タイプ別スニペット
3.2. 用途別スニペット
3.3. エンドユーザー別スニペット
4. ダイナミクス
4.1. 影響要因
4.1.1. 推進要因
4.1.1.1. 慢性疾患の増加
4.1.2. 阻害要因
4.1.2.1. 規制上のハードル
4.1.3. 機会
4.1.4. 影響分析
5. 産業分析
5.1. ポーターのファイブフォース分析
5.2. サプライチェーン分析
5.3. 価格分析
5.4. 規制分析
5.5. 償還分析
5.6. 特許分析
5.7. SWOT分析
5.8. DMI意見
6. 製品タイプ別
6.1. 製品紹介
6.1.1. 製品タイプ別市場規模分析および前年比成長率分析(%)
6.1.2. 市場魅力度指数（製品タイプ別
6.2. 埋め込み型輸液ポンプ
6.2.1. 序論
6.2.2. 市場規模分析と前年比成長率分析(%)
6.3. インスリン注入ポンプ
6.4. シリンジ輸液ポンプ
6.5. 定量注入ポンプ
6.6. その他
7. 用途別
7.1. 導入
7.1.1. 市場規模分析および前年比成長率分析（%）, アプリケーション別
7.1.2. 市場魅力度指数：用途別
7.2. 糖尿病*市場
7.2.1. 序論
7.2.2. 市場規模分析と前年比成長率分析(%)
7.3. 化学療法/腫瘍学
7.4. 消化器
7.5. 鎮痛／疼痛管理
7.6. 小児科／新生児科
7.7. 血液学
7.8. その他
8. エンドユーザー別
8.1. 導入
8.1.1. 市場規模分析および前年比成長率分析(%), エンドユーザー別
8.1.2. 市場魅力度指数、エンドユーザー別
8.2. 病院・クリニック*市場
8.2.1. はじめに
8.2.2. 市場規模分析と前年比成長率分析(%)
8.3. 外来ケア設定
8.4. 在宅ケア
8.5. 学術・研究機関
8.6. その他
9. 競争環境
9.1. 競争シナリオ
9.2. 市場ポジショニング／シェア分析
9.3. M&A分析
10. 企業プロフィール
10.1. Terumo Corporation*
10.1.1. 会社概要
10.1.2. 製品ポートフォリオと内容
10.1.3. 財務概要
10.1.4. 主な展開
10.2. Biomedix Medical, Inc.
10.3. B. Braun Medical
10.4. Nareena Lifesciences Private Limited
10.5. Becton, Dickinson and Company
10.6. Medtronic plc
10.7. Merck KGaA
10.8. Nipro Medical Corporation (*リストは除く)
11. 付録
11.1. 会社概要とサービス
11.2. お問い合わせ
Latin America Infusion Pumps Market reached US$ 106.90 million in 2023 and is expected to reach US$ 180.50 million by 2031, growing at a CAGR of 6.9% during the forecast period 2024-2031.
Infusion pumps are utilized extensively in the home and clinical environments such as nursing homes and hospitals. In contrast to manual administration, they provide numerous benefits, including the ability to administer fluids in minute quantities and at precisely programmed or automated intervals. They are utilized to administer medications or nutrients, including antibiotics, insulin or other hormones, painkillers, and chemotherapy medicines.
Infusion pumps allow for highly viscous medications to be administered through small catheters into the veins. Medication is usually administered this way through the dorsal veins of the hand, the forearm, the arm, the dorsal veins of the foot, the inguinal region and the antecubital fossa.
Market Dynamics: Drivers & Restraints
Increasing prevalence of chronic diseases
The rising chronic diseases are expected to drive the market growth. Rising chronic diseases are expected to increase the demand for infusion pumps to maintain the body fluids concentrations.
For instance, according to a report published by the National Institue of Health in 2023, during the three years (2023–2025), a total of 704,000 new cases of cancer occur each year in the country, excluding non-melanoma skin cancer, an estimated 244,000 occur in women and 239,000 in men. 70% of cases are expected for the South and Southeast regions. Breast cancer in women, prostate cancer, and colon and rectum are the three most frequent types in these two regions.
The increasing prevalence of chronic disorders due to the rapid growth of the geriatric population is increasing the use of infusion products in home care as well as hospitals. Thus, the above factors are expected to contribute to the growth of the Latin American infusion pump market.
Regulatory hurdles
Regulatory limitations involved with approving infusion pumps are projected to hinder industry growth. Ensuring that infusion pumps meet tight regulatory requirements pays significant costs. These can include costs for clinical investigations, paperwork, quality control procedures, and GMP compliance. Startups and smaller companies could find these expenses too costly.
Market Segment Analysis
The Latin America infusion pumps market is segmented based on product type, application, and end-user.
Insulin infusion pumps segment is expected to dominate the market share
Insulin infusion pumps hold a significant portion of the market share and are expected to continue throughout the forecast period. This is due to the increasing adoption of infusion pumps in the treatment of diabetic patients. The growing number of diabetic patients is also expected to be one of the major factors for the increasing demand for infusion pumps.
According to a report published by the National Institute of Health in 2024, it is stated that the prevalence of diabetes in Brazil is on the rise, with an estimated five million individuals currently affected by the disease. This number is expected to increase to 11 million by 2040.
With the increasing number of diabetic population, the demand for insulin infusion pumps is expected to rise which could contribute to the segment’s expansion. Thus, the above factors are expected to drive the segment growth and are expected to hold the segment in the dominant position.
Market Segmentation
By Product Type
Implantable Infusion Pumps
Insulin Infusion Pumps
Syringe Infusion Pumps
Volumetric Infusion Pumps
Others
By Application
Diabetes
Chemotherapy/Oncology
Gastroenterology
Analgesia/Pain Management
Pediatrics/Neonatology
Hematology
Others
By End-User
Hospitals & Clinics
Ambulatory Care Settings
Home Care Settings
Academic & Research Institutes
Others
Market Competitive Landscape
The major players in the market include Terumo Corporation, Biomedix Medical, Inc., B. Braun Medical, Nareena Lifesciences Private Limited, Becton, Dickinson and Company, Medtronic plc, Merck KGaA and Nipro Medical Corporation among others.
Why Purchase the Report?
To visualize the Latin America infusion pumps
Market Segmentation based on product type, application, and end-user, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of infusion pumps market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.
The Latin America infusion pumps market report would provide approximately 53 tables, 47 figures, and 176 pages.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End-User
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing prevalence of chronic diseases
4.1.2. Restraints
4.1.2.1. Regulatory hurdles
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. By Product Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Implantable Infusion Pumps*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Insulin Infusion Pumps
6.4. Syringe Infusion Pumps
6.5. Volumetric Infusion Pumps
6.6. Others
7. By Application
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Diabetes*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Chemotherapy/Oncology
7.4. Gastroenterology
7.5. Analgesia/Pain Management
7.6. Pediatrics/Neonatology
7.7. Hematology
7.8. Others
8. By End-User
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals & Clinics*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Care Settings
8.4. Home Care Settings
8.5. Academic & Research Institutes
8.6. Others
9. Competitive Landscape
9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis
10. Company Profiles
10.1. Terumo Corporation*
10.1.1. Company Overview
10.1.2. Product Portfolio and Description
10.1.3. Financial Overview
10.1.4. Key Developments
10.2. Biomedix Medical, Inc.
10.3. B. Braun Medical
10.4. Nareena Lifesciences Private Limited
10.5. Becton, Dickinson and Company
10.6. Medtronic plc
10.7. Merck KGaA
10.8. Nipro Medical Corporation (*LIST NOT EXHAUSTIVE)
11. Appendix
11.1. About Us and Services
11.2. Contact Us
*** 輸液ポンプの世界市場に関するよくある質問(FAQ) ***
・輸液ポンプの世界市場規模は？
→DataM Intelligence社は2023年の輸液ポンプの世界市場規模を1億690万米ドルと推定しています。
・輸液ポンプの世界市場予測は？
→DataM Intelligence社は2031年の輸液ポンプの世界市場規模を1億8,050万米ドルと予測しています。
・輸液ポンプ市場の成長率は？
→DataM Intelligence社は輸液ポンプの世界市場が2024年～2031年に年平均6.9%成長すると展望しています。
・世界の輸液ポンプ市場における主要プレイヤーは？
→「Terumo Corporation, Biomedix Medical, Inc., B. Braun Medical, Nareena Lifesciences Private Limited, Becton, Dickinson and Company, Medtronic plc, Merck KGaA and Nipro Medical Corporationなど ...」を輸液ポンプ市場のグローバル主要プレイヤーとして判断しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
